Palomar, Gillette renegotiate
This article was originally published in The Rose Sheet
Executive Summary
Firms have extended "launch decision" for a home-use, light-based hair removal device for women until no later than Feb. 29, 2008, according to Dec. 21 release. Palomar Medical Technologies says that under the existing development and license agreement - forged in February 2003 and amended and restated in February 2007 - Gillette was to make the launch decision by Jan. 7 (1"The Rose Sheet" Feb. 24, 2003, In Brief). However, companies have entered into negotiations for a new arrangement expected to include "the release of Palomar from exclusivity," in return for which "there would be a reduction in the percentage of net sales that Gillette pays to Palomar and a change from annual payments...to reduced calendar quarterly payments for a certain period," Palomar expects. There are no assurances that a new definitive agreement will be reached, the firm says, noting that the existing agreement could be terminated. L'Oréal also has been drawn to aesthetic devices; in December, the company announced a partnership with Light BioScience to co-develop stimulation devices for reducing wrinkles via light-emitting-diode photomodulation (2"The Rose Sheet" Dec. 17, 2007, In Brief)
You may also be interested in...
Gillette looks to lasers
Razor marketer signs agreement with laser hair removal research firm Palomar Medical Technologies to develop and "potentially" market a patented home-use, light-based hair removal device for women, the two firms announce Feb. 19. Gillette will pay up to $7 mil. to support product development over 30 months. Marketing laser hair removal products would "augment" Gillette's leading position in the razor category rather than cannibalize its existing business, company says, noting, "If the technology paradigm does shift in 20 years, Gillette wants to be shaping that"...
Patent Office Issues Proposed Rule For Rarely Successful Director Review Requests
The rulemaking is supposed to formalize the Patent Trial and Appeal Board process, which has been in an interim status since a Supreme Court decision, giving manufacturers more ability to request oversight of the decisions.
There’s ‘No Silver Bullet’ For Making Medicines Packaging Sustainable
There’s no simple answer to the question of how to make medicines packaging sustainable, says international recycling consultancy and Veolia Group subsidiary Circpack. “Manufacturers need to assess what works best for them, and recyclers will do the same,” Circpack analyst and circular packaging expert Filipe Vieira de Castro tells HBW Insight in this exclusive Q&A. “The best thing we can all do is put effort into finding common ground between systems, which comes down to better understanding the complexities between them.”